Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
Clinical trial NCT06630299 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06630299
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-08
- Primary completion
- 2026-04-23
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.